NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by a lymphocytic exocrinopathy. However, patients often have evidence of systemic autoimmunity, and they are at markedly increased risk for the development of non- Hodgkin's lymphoma. Similar to other autoimmune disorders, a strong interferon (IFN) signature is present among subsets of pSS patients, although the precise etiology remains uncertain. NCR3/NKp30 is a natural killer (NK)-specific activating receptor regulating the cross talk between NK and dendritic cells and type II IFN secretion. We performed a case-control study of genetic polymorphisms of the NCR3/NKp30 gene and found that rs11575837 (G>A) residing in the promoter was associated with reduced gene transcription and function as well as protection to pSS. We also demonstrated that circulating levels of NCR3/NKp30 were significantly increased among pSS patients compared with controls and correlated with higher NCR3/NKp30 but not CD16-dependent IFN-γ secretion by NK cells. Excess accumulation of NK cells in minor salivary glands correlated with the severity of the exocrinopathy. B7H6, the ligand of NKp30, was expressed by salivary epithelial cells. These findings suggest that NK cells may promote an NKp30-dependent inflammatory state in salivary glands and that blockade of the B7H6/NKp30 axis could be clinically relevant in pSS.

Citing Articles

Exploring structured molecular landscape from single-cell multi-omics data by an explainable multimodal model.

Tang H, Zhong J, Yu X, Chai H, Liu R, Zeng T iScience. 2024; 27(12):111131.

PMID: 39618495 PMC: 11607606. DOI: 10.1016/j.isci.2024.111131.

Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.

Ma D, Feng Y, Lin X Front Immunol. 2024; 15:1421436.

PMID: 39469708 PMC: 11513355. DOI: 10.3389/fimmu.2024.1421436.

Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment.

Meng Q, Ma J, Cui J, Gu Y, Shan Y Front Immunol. 2024; 15:1468469.

PMID: 39290700 PMC: 11405198. DOI: 10.3389/fimmu.2024.1468469.

Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis.

Bialy S, Iwaszko M, Swierkot J, Kolossa K, Wielinska J, Jeka S Immunol Res. 2024; 72(4):614-625.

PMID: 38714580 PMC: 11347466. DOI: 10.1007/s12026-024-09488-3.

Single-cell transcriptomics unveil profiles and interplay of immune subsets in rare autoimmune childhood Sjögren's disease.

Kim M, De U, Borcherding N, Wang L, Paek J, Bhattacharyya I Commun Biol. 2024; 7(1):481.

PMID: 38641668 PMC: 11031574. DOI: 10.1038/s42003-024-06124-6.

References

Yin H, Vosters J, Roescher N, Dsouza A, Kurien B, Tak P . Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome. PLoS One. 2011; 6(3):e18003. PMC: 3065457. DOI: 10.1371/journal.pone.0018003. View

Gottenberg J, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T . Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A. 2006; 103(8):2770-5. PMC: 1413808. DOI: 10.1073/pnas.0510837103. View

Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T . The regulatory role of natural killer cells in multiple sclerosis. Brain. 2004; 127(Pt 9):1917-27. DOI: 10.1093/brain/awh219. View

Gottenberg J, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D . In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003; 48(8):2240-5. DOI: 10.1002/art.11103. View

Ferlazzo G, Tsang M, Moretta L, Melioli G, Steinman R, Munz C . Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002; 195(3):343-51. PMC: 2193591. DOI: 10.1084/jem.20011149. View

Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L . NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005; 106(2):566-71. DOI: 10.1182/blood-2004-10-4035. View

Al-Hubeshy Z, Coleman A, Nelson M, Goodier M . A rapid method for assessment of natural killer cell function after multiple receptor crosslinking. J Immunol Methods. 2011; 366(1-2):52-9. DOI: 10.1016/j.jim.2011.01.007. View

Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, Cilli M . Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood. 2005; 106(12):3846-53. DOI: 10.1182/blood-2005-05-2034. View

Wildenberg M, Welzen-Coppens J, van Helden-Meeuwsen C, Bootsma H, Vissink A, van Rooijen N . Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjögren syndrome. Ann Rheum Dis. 2008; 68(3):420-6. DOI: 10.1136/ard.2008.087874. View

10.

Alunno A, Bistoni O, Bartoloni E, Caterbi S, Bigerna B, Tabarrini A . IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Ann Rheum Dis. 2012; 72(2):286-92. DOI: 10.1136/annrheumdis-2012-201511. View

11.

Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P . Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res. 2011; 71(16):5412-22. DOI: 10.1158/0008-5472.CAN-10-4179. View

12.

Chiorini J, cihakova D, Ouellette C, Caturegli P . Sjögren syndrome: advances in the pathogenesis from animal models. J Autoimmun. 2009; 33(3-4):190-6. PMC: 3439154. DOI: 10.1016/j.jaut.2009.09.009. View

13.

Greenspan J, Daniels T, Talal N, Sylvester R . The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974; 37(2):217-29. DOI: 10.1016/0030-4220(74)90417-4. View

14.

Dimitriou I, Kapsogeorgou E, Abu-Helu R, Moutsopoulos H, Manoussakis M . Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci. 2002; 110(1):21-30. DOI: 10.1034/j.1600-0722.2002.00152.x. View

15.

Nguyen C, Yin H, Lee B, Carcamo W, Chiorini J, Peck A . Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther. 2010; 12(6):R220. PMC: 3046533. DOI: 10.1186/ar3207. View

16.

Szodoray P, Papp G, Horvath I, Barath S, Sipka S, Nakken B . Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin Exp Immunol. 2009; 157(3):343-9. PMC: 2745027. DOI: 10.1111/j.1365-2249.2009.03966.x. View

17.

Nguyen C, Hu M, Li Y, Stewart C, Peck A . Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum. 2008; 58(3):734-43. PMC: 2850059. DOI: 10.1002/art.23214. View

18.

Ohlsson M, Jonsson R, Brokstad K . Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol. 2002; 56(5):456-69. DOI: 10.1046/j.1365-3083.2002.01072_79.x. View

19.

Dawson L, Fox P, Smith P . Sjogrens syndrome--the non-apoptotic model of glandular hypofunction. Rheumatology (Oxford). 2006; 45(7):792-8. DOI: 10.1093/rheumatology/kel067. View

20.

Bryceson Y, Rudd E, Zheng C, Edner J, Ma D, Wood S . Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007; 110(6):1906-15. PMC: 1976360. DOI: 10.1182/blood-2007-02-074468. View